These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 30886142)

  • 1. Generic synthesis of small-sized hollow mesoporous organosilica nanoparticles for oxygen-independent X-ray-activated synergistic therapy.
    Fan W; Lu N; Shen Z; Tang W; Shen B; Cui Z; Shan L; Yang Z; Wang Z; Jacobson O; Zhou Z; Liu Y; Hu P; Yang W; Song J; Zhang Y; Zhang L; Khashab NM; Aronova MA; Lu G; Chen X
    Nat Commun; 2019 Mar; 10(1):1241. PubMed ID: 30886142
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acidity/Reducibility Dual-Responsive Hollow Mesoporous Organosilica Nanoplatforms for Tumor-Specific Self-Assembly and Synergistic Therapy.
    Tang W; Fan W; Wang Z; Zhang W; Zhou S; Liu Y; Yang Z; Shao E; Zhang G; Jacobson O; Shan L; Tian R; Cheng S; Lin L; Dai Y; Shen Z; Niu G; Xie J; Chen X
    ACS Nano; 2018 Dec; 12(12):12269-12283. PubMed ID: 30418749
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hollow mesoporous organosilica nanoparticles: a generic intelligent framework-hybridization approach for biomedicine.
    Chen Y; Meng Q; Wu M; Wang S; Xu P; Chen H; Li Y; Zhang L; Wang L; Shi J
    J Am Chem Soc; 2014 Nov; 136(46):16326-34. PubMed ID: 25343459
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Merging metal organic framework with hollow organosilica nanoparticles as a versatile nanoplatform for cancer theranostics.
    Chen L; Zhang J; Zhou X; Yang S; Zhang Q; Wang W; You Z; Peng C; He C
    Acta Biomater; 2019 Mar; 86():406-415. PubMed ID: 30625415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Schiff base interaction tuned mesoporous organosilica nanoplatforms with pH-responsive degradability for efficient anti-cancer drug delivery in vivo.
    Liu L; Kong C; Huo M; Liu C; Peng L; Zhao T; Wei Y; Qian F; Yuan J
    Chem Commun (Camb); 2018 Aug; 54(66):9190-9193. PubMed ID: 30062359
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interface-Engineered Paclitaxel-Based Hollow Mesoporous Organosilica Nanoplatforms for Photothermal-Enhanced Chemotherapy of Tumor.
    Qian C; Al-Hamyari B; Tang X; Hou B; Yang S; Zhang G; Lv H; Yang Z; Wang Z; Shi Y
    Mol Pharm; 2021 Dec; 18(12):4531-4542. PubMed ID: 34739255
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Facile Synthesis of Yolk-Shell-Structured Triple-Hybridized Periodic Mesoporous Organosilica Nanoparticles for Biomedicine.
    Teng Z; Zhang J; Li W; Zheng Y; Su X; Tang Y; Dang M; Tian Y; Yuwen L; Weng L; Lu G; Wang L
    Small; 2016 Jul; 12(26):3550-8. PubMed ID: 27183872
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Photo-responsive degradable hollow mesoporous organosilica nanoplatforms for drug delivery.
    Fan J; Zhang Z; Wang Y; Lin S; Yang S
    J Nanobiotechnology; 2020 Jun; 18(1):91. PubMed ID: 32539777
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biodegradable reduce expenditure bioreactor for augmented sonodynamic therapy via regulating tumor hypoxia and inducing pro-death autophagy.
    Zou W; Hao J; Wu J; Cai X; Hu B; Wang Z; Zheng Y
    J Nanobiotechnology; 2021 Dec; 19(1):418. PubMed ID: 34903226
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fabrication of multifunctional triple-responsive platform based on CuS-capped periodic mesoporous organosilica nanoparticles for chemo-photothermal therapy.
    Cheng X; Li D; Lin A; Xu J; Wu L; Gu H; Huang Z; Liu J; Zhang Y; Yin X
    Int J Nanomedicine; 2018; 13():3661-3677. PubMed ID: 29983561
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Tumor Microenvironment-Responsive Biodegradable Mesoporous Nanosystem for Anti-Inflammation and Cancer Theranostics.
    Wu J; Niu S; Bremner DH; Nie W; Fu Z; Li D; Zhu LM
    Adv Healthc Mater; 2020 Jan; 9(2):e1901307. PubMed ID: 31814332
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biomimetic Diselenide-Bridged Mesoporous Organosilica Nanoparticles as an X-ray-Responsive Biodegradable Carrier for Chemo-Immunotherapy.
    Shao D; Zhang F; Chen F; Zheng X; Hu H; Yang C; Tu Z; Wang Z; Chang Z; Lu J; Li T; Zhang Y; Chen L; Leong KW; Dong WF
    Adv Mater; 2020 Dec; 32(50):e2004385. PubMed ID: 33164250
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Precision Cancer Theranostic Platform by In Situ Polymerization in Perylene Diimide-Hybridized Hollow Mesoporous Organosilica Nanoparticles.
    Yang Z; Fan W; Zou J; Tang W; Li L; He L; Shen Z; Wang Z; Jacobson O; Aronova MA; Rong P; Song J; Wang W; Chen X
    J Am Chem Soc; 2019 Sep; 141(37):14687-14698. PubMed ID: 31466436
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    Li T; He F; Liu B; Jia T; Shao B; Zhao R; Zhu H; Yang D; Gai S; Yang P
    ACS Appl Mater Interfaces; 2020 Dec; 12(51):56886-56897. PubMed ID: 33290033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Construction and Biological Evaluation of Multiple Modification Hollow Mesoporous Silicone Doxorubicin Nanodrug Delivery System.
    Hu M; Zhang W; Chen W; Chen Y; Huang Q; Bao Q; Lin T; Wang L; Zhang S
    AAPS PharmSciTech; 2022 Jun; 23(6):180. PubMed ID: 35761120
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biodegradable Hollow Mesoporous Organosilica Nanotheranostics for Mild Hyperthermia-Induced Bubble-Enhanced Oxygen-Sensitized Radiotherapy.
    Lu N; Fan W; Yi X; Wang S; Wang Z; Tian R; Jacobson O; Liu Y; Yung BC; Zhang G; Teng Z; Yang K; Zhang M; Niu G; Lu G; Chen X
    ACS Nano; 2018 Feb; 12(2):1580-1591. PubMed ID: 29384652
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radiotherapy-Controllable Chemotherapy from Reactive Oxygen Species-Responsive Polymeric Nanoparticles for Effective Local Dual Modality Treatment of Malignant Tumors.
    Liu TI; Yang YC; Chiang WH; Hung CK; Tsai YC; Chiang CS; Lo CL; Chiu HC
    Biomacromolecules; 2018 Sep; 19(9):3825-3839. PubMed ID: 30044907
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of mesoporous silica nanoparticles and mesoporous organosilica nanoparticles as drug vehicles for cancer therapy.
    Yue J; Luo SZ; Lu MM; Shao D; Wang Z; Dong WF
    Chem Biol Drug Des; 2018 Aug; 92(2):1435-1444. PubMed ID: 29671941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecularly organic/inorganic hybrid hollow mesoporous organosilica nanocapsules with tumor-specific biodegradability and enhanced chemotherapeutic functionality.
    Huang P; Chen Y; Lin H; Yu L; Zhang L; Wang L; Zhu Y; Shi J
    Biomaterials; 2017 May; 125():23-37. PubMed ID: 28226244
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Large Pore-Sized Hollow Mesoporous Organosilica for Redox-Responsive Gene Delivery and Synergistic Cancer Chemotherapy.
    Wu M; Meng Q; Chen Y; Zhang L; Li M; Cai X; Li Y; Yu P; Zhang L; Shi J
    Adv Mater; 2016 Mar; 28(10):1963-9. PubMed ID: 26743228
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.